SV2A and epilepsy: This finding implies that the mechanisms involved in the sv2a loss-of-function model at least partly differ from those observed in the other zebrafish epilepsy models, highlighting not only the novelty and uniqueness of our model, but also its potential use for drug screening to find AEDs with novel mechanisms of action.